Analysis of the Relationship between Medication Adherence and Quality of Life of Prolanis patients at First Level Health Facilities in Kendari City

Chronic disease management programs are part of health services that aim to help maintain patient health. One focus of the program is the maintenance of hypertension and diabetes mellitus. The success of therapy is adherence with taking medication. Adherence with taking medication can have a good impact on a person’s quality of life. In this study, we focused on the hypertension and diabetes mellitus prolanis group. The aim of this research is to obtain data on the level of adherence to taking medication of prolanis patients, the value of the quality of life (utility) of prolanis patients and the relationship between the level of adherence to taking medication and the quality of life of prolanis patients. The research was carried out at first-level health facilities in the city of Kendari, namely 4 health centers were selected. They were Lepo-lepo health center, poasia health center, wua-wua health center and mokoau health center. Retrieval of research data lasted for 1 month. The research instruments used were the MMAS-8 to measure adherence to medication in prolanis patients and the EQ-5D-5L to measure the patient’s quality of life. Analysis of the relationship between the level of medication adherence to the quality of life of prolanis patients was analyzed using the bivariate-spearman rank test. The results of the study showed that the level of adherence to medication in prolanis patients was categorized as adherent (15.7%) medium (18.2%) and non-adherent (66.1%). The quality of life of prolanis patients is categorized as good for measurement using the EQ-5D-5L or VAS. The utility value for quality of life is 0.745, the highest utility value is 1.0 while the lowest is 0.10. There is a significant relationship between the level of medication adherence and the quality of life of prolanis patients.